Literature DB >> 12880012

Comparison of efficacy and tolerability of isoflupredone and dexamethasone in the treatment of horses affected with recurrent airway obstruction ('heaves').

V Picandet1, R Léguillette, J P Lavoie.   

Abstract

REASONS FOR PERFORMING STUDY: Corticosteroids are currently the most effective drugs for the control of 'heaves' in horses. However, there is limited information concerning the comparative efficacy and tolerability of the various corticosteroids when used for treatment.
OBJECTIVES: To compare the therapeutic and side effects of isoflupredone acetate to those of dexamethasone.
METHODS: A parallel design to compare the effects of 2 corticosteroids by evaluating lung function, serum cortisol and electrolyte concentrations, response to ACTH stimulation and haematology sequentially during a 14 day control period (no treatment), followed by 14 day treatment with either isoflupredone acetate (0.03 mg/kg i.m. s.i.d., n = 6) or dexamethasone (0.04 mg/kg i.v. s.i.d., n = 6) and 7 days of wash-out.
RESULTS: Both drugs were well tolerated clinically and resulted in a significant improvement in lung function that started on Day 3 and lasted for the treatment and wash-out periods. Blood cortisol levels were significantly decreased during the treatment period in both groups of horses, but a normal response to ACTH stimulation was preserved. Serum electrolytes concentration of horses receiving dexamethasone was not affected by the treatment, but horses treated with isoflupredone demonstrated a significant decrease in serum potassium level. Both treatments induced stress changes in haematology. CONCLUSIONS AND POTENTIAL RELEVANCE: Isoflupredone is as effective as dexamethasone in the treatment of 'heaves'-affected horses but associated with hypokalaemia. Even if clinical signs of hypokalaemia were not observed, this is a side effect that deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880012     DOI: 10.2746/042516403776014208

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  6 in total

Review 1.  Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?

Authors:  Ann Kristin Barton; Heidrun Gehlen
Journal:  Mediators Inflamm       Date:  2016-12-07       Impact factor: 4.711

2.  Effect of injected dexamethasone on relative cytokine mRNA expression in bronchoalveolar lavage fluid in horses with mild asthma.

Authors:  Stephanie L Bond; Jana Hundt; Renaud Léguillette
Journal:  BMC Vet Res       Date:  2019-11-06       Impact factor: 2.741

3.  Effect of Dexamethasone and Fluticasone on Airway Hyperresponsiveness in Horses With Inflammatory Airway Disease.

Authors:  R Léguillette; T Tohver; S L Bond; J A Nicol; K J McDonald
Journal:  J Vet Intern Med       Date:  2017-05-31       Impact factor: 3.333

4.  Efficacy of inhaled budesonide for the treatment of severe equine asthma.

Authors:  J P Lavoie; M Leclere; N Rodrigues; K R Lemos; C Bourzac; J Lefebvre-Lavoie; G Beauchamp; B Albrecht
Journal:  Equine Vet J       Date:  2018-09-25       Impact factor: 2.888

5.  Effect of intrabronchial administration of autologous adipose-derived mesenchymal stem cells on severe equine asthma.

Authors:  Neža Adamič; Sonja Prpar Mihevc; Rok Blagus; Petra Kramarič; Uroš Krapež; Gregor Majdič; Laurent Viel; Andrew M Hoffman; Dorothee Bienzle; Modest Vengust
Journal:  Stem Cell Res Ther       Date:  2022-01-21       Impact factor: 6.832

6.  Inhaled ciclesonide is efficacious and well tolerated in the treatment of severe equine asthma in a large prospective European clinical trial.

Authors:  Robert Scott Pirie; Hanns-Walter Mueller; Odilo Engel; Balazs Albrecht; Marcella von Salis-Soglio
Journal:  Equine Vet J       Date:  2021-01-28       Impact factor: 2.888

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.